1. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence;Olsen;Obstet Gynecol,1997
2. US Food and Drug Administration. FDA safety communication: update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. 2011. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm. Accessed July 13, 2011.
3. FDA public health notification: serious complications associated with transvaginal placement of surgerical mesh in repair of pelvic organ prolase and stress urinary incontinence. 2008. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm061976.htm. October 20, 2008.
4. Mesh social networking: a patient-driven process;Yanagisawa;BJU Int,2011
5. Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse;Maher;Cochrane Database Syst Rev,2016